We reported that complement (C) becomes activated and cleaved in bone marrow during preconditioning for hematopoietic transplantation and the third C component (C3) cleavage fragments, C3a and desArg C3a, increase responsiveness of hematopoietic stem/progenitor cells (HSPCs) to stromal-derived factor-1 (SDF-1). We also showed that this homing-promoting effect is not C3a receptor (C3aR) dependent. Herein, we report our new observation that transplantation of C3aR À/À HSPCs into lethally irradiated recipients results in:
Introduction
The collective term 'homing' refers to the early stages of bone marrow (BM) seeding by hematopoietic stem/progenitor cells (HSPCs) after transplantation, which precedes engraftment, proliferation and differentiation of these cells. In general, homing, engraftment and expansion of HSPCs after transplantation are closely related processes, although all the factors involved have not been identified. 1, 2 However, it has been shown that a-chemokine stromal-derived factor-1 (SDF-1)-chemokine receptor CXCR4 axis and vascular cell adhesion molecule 1 (VCAM-1)-very late antigen-4 (VLA-4) interactions play important roles in these processes. Although SDF-1 secreted by BM stroma chemoattracts intravenously infused CXCR4 þ HSPCs, VCAM-1 expressed on BM endothelium interacts with and tethers VLA-4 (a4/b1 integrin) þ HSPCs. [3] [4] [5] [6] [7] [8] [9] [10] [11] It is well known that conditioning for transplantation by chemo/radiotherapy destroys old hematopoiesis, and by emptying hematopoietic niches, makes space available for transplanted cells and highly upregulates expression of SDF-1 in the BM microenvironment, which creates a proper chemoattracting gradient for HSPCs. [12] [13] [14] In addition, SDF-1 activates adhesion molecules on HSPCs (for example, VLA-4), which promotes their adhesion and upregulates secretion of metaloproteinases (for example, matrix metalloprotease-9 (MMP-9)) by these cells. All these processes orchestrate transendothelial migration of HSPCs into the BM microenvironment. 3, 5, 6, [9] [10] [11] [15] [16] [17] We have recently reported that myeloablative conditioning for transplants by radio/chemotherapy activates complement (C) cascade in BM as well. [18] [19] The protein components of C, including the third C component (C3), are activated through proteolysis in a cascade-like manner leading to the generation of 'liquid-phase' activation peptides with potent pro-inflammatory properties termed anaphylatoxins (C3a and desArg C3a), as well as activated/cleaved 'solid-phase' proteins that bind to the surface of C-activating cells (for example, iC3b). C3 cleavage fragments bind to specific C3 receptors that are expressed on several types of cells, including HSPCs [18] [19] [20] [21] [22] Although C3a binds to G-proteincoupled, seven transmembrane-spanning C3a receptor (C3aR) and C5L2, C3a desÀArg binds to C5L2 only. The receptor for iC3b is CR3 and is the a M b 2 -integrin, which is also known as CD11b/ CD18 or Mac-1. [22] [23] [24] [25] [26] [27] We reported earlier that C3 liquid-phase cleavage fragments (C3a and desArg C3a) enhance responsiveness of HSPCs to SDF-1 gradient. The molecular explanation of this phenomenon is on the basis of our observation that both C3a and desArg C3a increase incorporation of CXCR4 into membrane lipid rafts, thus facilitating its more effective assembly with downstream signaling molecules. 18, 22, 23, 28 In addition, C3a, but not desArg C3a, enhances secretion of MMP-9 in HSPCs and increases adhesion of these cells to VCAM-1. As a result, HSPCs primed before transplantation by C3a, but not desArg C3a, home and engraft better. 23 On the other hand, iC3b deposited on cells in the BM microenvironment tethers HSPCs through CR3. To support this, we found that C3-deficient mice engraft poorly with HSPCs. 18, 22, 29 As C3aR À/À cells show normal priming effect after C3a stimulation, 18, 22, 29 we hypothesized that this phenomenon does not involve C3aR. However, to better address whether C3aR is also directly involved in engraftment, we employed HSPCs from C3aR À/À mice and compared their homing and engraftment characteristics to wild-type (WT) counterparts. Our data provides the first evidence that C3a increases homing responses of HSPCs by direct interaction with C3aR and that another C3a binding receptor (C5L2 receptor) cannot compensate for C3aR deficiency. We conclude that C3a plays an important but underappreciated role in engraftment of HSPCs by increasing non-C3aR-dependent responsiveness of HSPCs to SDF-1 gradient and by C3aR-mediated increase in MMP-9 secretion and cell adhesion.
Materials and methods

Murine bone marrow-derived cells
Animal studies were approved by the Institutional Animal Care and Use Committee of the University of Louisville. Murine BM mononuclear cells were flushed from the femora of BALB/c C3aR þ / þ and BALB/c C3aR À/À (The Jackson Laboratory, Bar Harbor, ME, USA). The protocols used were approved by the appropriate institutional ethics review boards. MNCs were depleted of adherent cells (A À ) and then enriched for lightdensity MNCs by Ficoll-Paque centrifugation. Sca-1 þ cells were isolated using paramagnetic mini-beads (Miltenyi Biotec, Auburn, CA, USA). The purity of isolated BM Sca-1 þ cells was 495%, as determined by fluorescein-activated cell sorting (FACS). For some of the transplant experiments, Sca-1 þ kit þ lin À (SKL) cells were purified by employing MoFlo sorter as described. 18 Human umbilical cord blood (UCB)-derived cells Human light-density UCB cells were obtained after informed consent; the protocols used were approved by the appropriate institutional ethics review boards. Light-density cells were depleted of adherent cells and T lymphocytes (A-T-MNCs), and enriched for CD34 þ cells by immunoaffinity selection with MiniMACS paramagnetic beads (Miltenyi Biotec). The purity of isolated BM CD34 þ cells was 495%, as determined by FACS analysis using a FACscan (Becton Dickinson, San Jose, CA, USA). Human BM CD34 þ transplants were carried out on nonobese diabetic/severe combined immunodeficient (NOD/SCID) inbred mice (The Jackson Laboratory).
Adhesion assay
Wild-type BM stroma was grown to confluence, and WT or C3aR À/À Sca-1 þ cells were non-stimulated or stimulated by C3a (1 mg/ml) or desArg C3a (1 mg/ml) and added to the cultures for either 1 or 3 h. Non-adhered cells were washed off. Subsequently, the entire cultures were trypsinized and plated in methylcellulose cultures and stimulated to grow colony-forming units-granulocyte-macrophage (CFU-GM) colonies as described. 18 The number of colonies was scored under an inverted microscope.
Zymography
To evaluate MMP-9 secretion by Sca-1 þ , 2 Â 10 6 cells/ml were incubated (for 24 h at 37 1C in 5% CO 2 ) in the absence or presence of C3a or desArg C3a (1 mg/ml), and cells were isolated for reverse transcriptase-PCR analysis of mRNA expression for MMP-2 and MMP-9, and cell-conditioned media were analyzed immediately by zymography as described earlier by us. 23 The intensity of the bands was quantified using the NIH ScionImage for Windows software (Scion Corp., Frederick, MD, USA).
Short-term homing assays
Mice were irradiated with a lethal dose of g-irradiation (900 cGy). After 24 h, the mice were transplanted (by tail vein injection) with 2 Â 10 5 BM Sca-1 þ cells. At 6 or 24 h after transplant, BM was harvested from the femurs and plated in serum-free methylcellulose cultures and stimulated to grow CFU-GM colonies by stimulation with granulocyte macrophagecolony stimulating factor (GM-CSF) (25 ng/ml) þ interleukin (IL)-3 (10 ng/ml).
Bone marrow transplantation
For transplant experiments, mice were irradiated with a lethal dose of g-irradiation (900 cGy). After 24 h, mice were transplanted with 10 5 BM Sca-1 þ cells or 10 4 Sca-1 þ kit þ lin À (SKL) cells by tail vein injection. Anesthetized transplanted mice were bled at various intervals from the retro-orbital plexus to obtain samples for leukocytes and platelets.
Evaluation of engraftment
Colony-forming units-spleen (S) assay. For the colonyforming units-spleen (CFU-S) assays, mice were transplanted with 5 Â 10 4 Sca-1 þ marrow cells. At day 12, spleens were removed, fixed in Telesyniczky's solution and CFU-S colonies were counted on the surface of the spleen as described. 18 Number of colony-forming units-granulocyte-macrophage/femur. Femora of transplanted mice were flushed with phosphate-buffered saline (PBS) at day 16 post-transplant. Subsequently, Sca-1 þ cells were purified and plated in serumfree methylcellulose cultures and stimulated to grow CFU-GM colonies by granulocyte-colony stimulating factor (G-CSF; 25 ng/ml) þ IL-3 (10 ng/ml).
Statistical analysis
Arithmetic means and s.d. were calculated using Instat 1.14 software (Graphpad, San Diego, CA, USA). Statistical significance was defined as Po0.05. Data were analyzed using Student's t-test for unpaired samples.
Results
Delayed engraftment after transplantation of C3aR À/À HSPCs
We reported that C3aR À/À mice or WT mice in which C3aR is blocked by small molecular antagonist SB 290157 are easy mobilizers in response to G-CSF. 30, 31 This could indicate that C3aR plays an important role in retention of HSPCs in the BM microenvironment.
To better address this question, we carried out hematopoietic transplantation experiments using HSPCs from C3aR À/À and WT mice to both WT and C3aR À/À animals. As shown in Figure 1a , the kinetics of white blood cell (WBC) and platelet counts showed delayed engraftment of C3aR À/À HSPCs. Next, to exclude a potential contribution of C3aR deficiency on cells in the hematopoietic environment, we carried out transplants into C3aR À/À recipients ( Figure 1b ) and noticed that C3aR À/À HSPCs also show delayed engraftment as compared with WT HSPCs. Thus, regardless of the genetic background of the recipient animal, C3aR À/À HSPCs do not engraft, as well as their WT counterparts.
Our WBC and platelet counts recovery kinetic data were subsequently confirmed by evaluating the number of: (a) day 11 CFU-S (Figures 2a) and (b) cells able to grow CFU-GM colonies that were recovered at day 16 from the femora of transplanted mice (Figure 2b ), or in WT mice transplanted either with C3aR À/À or WT HSPCs. Next, similar results were obtained after transplantation of HSPCs from C3aR À/À or WT mice to C3aR À/À deficient animals (not shown). Thus, our data showed an engraftment defect of C3aR À/À HSPCs, and also showed that this defect does not depend on C3aR expression in the BM microenvironment. Therefore, these data clearly demonstrate that C3a modulates engraftment, and that some of its effects are mediated by its direct interaction with C3aR on HSPCs.
C3aR À/À cells show defective homing to bone marrow
Homing is the first step of BM seeding by HSPCs after transplantation, which precedes their engraftment, proliferation and differentiation. As we showed that the C3a-C3aR axis is not involved in proliferation of HSPCs, 23 we asked whether delayed recovery of hematopoiesis in mice transplanted with C3aR À/À cells could be explained by their defective homing and lodgment to the BM microenvironment.
To address this issue, we used short-homing assay to evaluate lodging of HSPCs to BM. Accordingly, WT mice were lethally irradiated and, 24 h later, they were transplanted with C3aR À/À or WT HSPCs. Subsequently, animals were killed 6 or 24 h after transplantation, the femora were removed, and BM cells were isolated and plated in methylocelluose cultures to grow CFU-GM colonies (Figure 3a ). By using this assay, we found that C3aR À/À HSPCs show defective homing and lodging to the BM Figure 1 Hematopoietic stem/progenitor cells from C3aR À/À mice show defective engraftment. This is shown by a delayed recovery of platelets and leukocytes. (a) Lethally irradiated WT mice were transplanted with SKL cells (10 4 per mouse) isolated from C3aR À/À and WT animals. Recovery of platelet and leukocyte counts was evaluated at days 0, 5, 7, 11, 16 and 28. (b) Lethally irradiated C3aR À/À mice were transplanted with SKL cells isolated from C3aR À/À and WT animals. Recovery of platelet and leukocyte counts was evaluated at days 0, 5, 7, 11, 16 and 28. The data shown represent the combined results from three independent experiments carried out with 10 mice per group. *Po0.0001. All mice in irradiation control (non-transplanted) died before day 14 (not shown).
Figure 2
Hematopoietic stem/progenitor cells from C3aR À/À mice show decrease in day 11 colony-forming units-spleen (CFU-S) formation and content of day 16 colony-forming units-granulocyte-macrophage (CFU-GM)/femur. (a) Lethally irradiated WT mice were transplanted with Sca-1 þ cells isolated from C3aR À/À and WT animals. CFU-S colonies were counted 11 days after transplantation. Inset. Examples of spleens with CFU-S colonies. The data shown represent the combined results from three independent experiments carried out with 10 mice per group. *Po0.0001. All mice in irradiation control (non-transplanted) did not have any endogenous CFU-S colonies and died before day 14. (b) Lethally irradiated WT mice were transplanted with Sca-1 þ cells isolated from C3aR À/À and WT animals. Bone marrow from the femora of transplanted mice was isolated, and the contents of CFU-GM and femurs were evaluated in secondary in vitro cultures. The data shown represent the combined results from three independent experiments carried out with six mice per group. *Po0.003. All mice in irradiation control (non-transplanted) died before day 14. microenvironment. This defective lodging could be the result of defective transendothelial migration of HSPCs to cells in the BM microenvironment.
To further address this question, we carried out in vitro adhesion studies with sorted Sca-1 þ cells. Accordingly, Sca-1 þ cells isolated from the BM of C3aR À/À or WT mice were nonexposed, or exposed for 30 min to C3a or desArg C3a, and subsequently plated over BM-derived irradiated stroma feeder layers established in well plates. Subsequently, at 1 and 3 h later, plates were gently shaken and non-adherent cells were discarded. Finally, cells remaining in the wells were trypsinized and plated in methylcellulose to grow CFU-GM colonies. We noticed that C3a, but not desArg C3a, increased adhesion in WT but not C3aR À/À HSPCs (Table 1 ). On the basis of this, the C3a-C3aR axis seems to be involved in increasing adhesion of HSPCs. Furthermore, a similar effect was observed for WT and C3aR À/À HSPCs in adhesion assay to C3aR À/À stroma (Figure 3b ). As stimulation by desArg C3a was ineffective to compensate the C3aR deficiency in C3aR À/À cells, which express C3a and desArg C3a binding C5L2 receptor, we excluded the potential involvement of C5L2 in these phenomena.
C3a-C3aR axis regulates secretion of matrix metalloprotease-9 by HSPCs
After adhesion to endothelium, HSPCs have to migrate through the endothelial basement membrane in a process that involves secretion of proteolytic enzymes. MMP-9 was shown to play a pivotal role here. In our earlier studies, we showed that C3a stimulates secretion of MMP-9 by HSPCs. 23 To address the importance of C3aR in this phenomenon, we exposed BM-derived Sca-1 þ cells isolated from C3aR À/À and WT to C3a or desArg C3a, and evaluated MMP-9 expression at the mRNA (Figure 4a ) and protein ( Figure 4b ) levels. We noticed that C3a, but not desArg C3a, upregulates expression of MMP-9 in WT, but not C3aR À/À cells. Again, because stimulation by desArg C3a was ineffective to compensate the C3aR deficiency in C3aR À/À cells that express C3a and desArg C3a binding C5L2 receptor, we excluded the potential involvement of C5L2 in this phenomenon.
C3aR also plays a role in engraftment of human HSPCs
Finally, to address the role of C3aR in homing of human HSPCs, we carried out xenotransplants in NOD/SCID mice ( Figure 5 ). Human UCB-purified human CD34 þ cells were pre-incubated or not exposed to C3aR antagonist SB 290157 and transplanted into lethally irradiated NOD/SCID mice 24 h after an irradiation that eliminated murine endogenous HSPCs. Subsequently, 24 h after transplantation of human UCBs, we recovered cells from the femora of transplanted mice and plated them in methylcellulose cultures to growth colonies in the presence of human hematopoietic factors. We noticed that the number of human CFU-GM progenitors recovered from the murine femora was significantly lower in animals transplanted with UCB CD34 þ cells in which C3aR was blocked by SB 290157 (Figure 5) , Figure 3 Hematopoietic stem/progenitor cells from C3aR À/À mice show defective homing in vivo. (a) Lethally irradiated WT mice were transplanted with Sca-1 þ cells isolated from C3aR À/À or WT animals. At 6 and 24 h later, bone marrow from the femora of transplanted mice was isolated, and the contents of colony-forming units-granulocyte-macrophage (CFU-GM) and femurs were evaluated in secondary in vitro cultures. The data shown represent the combined results from three independent experiments carried out with six mice/group. *Po0.0237 for 6 h and *Po0.0016 for 24 h. No colonies grew from lethally irradiated and non-transplanted animals. (b) The number of CFU-GM from Sca-1 þ cells from WT mice that adhered to C3aR À/À stroma stimulated for 30 min by C3a was arbitrarily assumed to be 100% in 1 and 3 h adhesion assays. The data shown represent the combined results from three independent experiments (n ¼ 12). *Po0.0001.
Table 1
The C3a-C3aR axis enhances adhesion of BM-derived Sca-1 + cells to BM stroma which also implicates a role of C3aR in homing of human HSPCs. Of note, in control experiments, no CFU-GM colonies were grown from BM cells recovered from lethally irradiated NOD/SCID mice that did not receive human UCB cells (not shown).
Source of Sca-1 + cells (adhesion time)
Discussion
The a-chemokine SDF-1 is upregulated in the BM microenvironment after conditioning for transplantation by radio-chemotherapy, which is a crucial chemoattractant for intravenously infused. 1, 2, 4, 12, 13 However, the biological activity of the SDF-1-CXCR4 axis is modulated by several factors. For example, data from our laboratory showed that during conditioning for transplantation, C cascade is activated. Although C3 liquid-phase cleavage fragments (C3a and desArg-C3a) prime and enhance responsiveness of HSPCs to SDF-1 gradient, 22, 23, 28, 29 solid-phase iC3b tethers HSPCs to BM stroma. 18 In agreement with this, we have earlier shown that HSPCs poorly engraft after transplantation into C3 À/À mice. 18 We have explained this defective engraftment in C3 À/À mice as a lack of generated C3a and desArg C3a, which enhance responsiveness of HSPCs to SDF-1 gradient. 18, 28 To our surprise, however, we noticed that C3 cleavage fragments increase responsiveness of HSPCs to SDF-1 gradient in vitro ,and that this effect does not seem to be C3aR dependent. In support of this, we showed that cells from WT and C3aR À/À mice respond equally to priming effect to both C3a and desArg C3a. 18 On the other hand, we have also shown earlier that C3aR À/À mice, as well as WT animals exposed to C3aR antagonist SB290157, are easy G-CSF mobilizers. 30, 31 This latter observation prompted us to investigate whether C3a-C3aR may play a role in the retention of HSPCs in BM, which could be a potentially novel role of C3a independent of its priming effect on HSPCs.
Here, we show for the first time that transplantation of murine C3aR À/À HSPCs results in delayed engraftment and hematopoietic recovery of lethally irradiated mice. As C3aR À/À animals engraft normally with WT cells, this defect is intrinsic to HSPCs and does not depend on C3aR expressed on cells in the hematopoietic microenvironment. More importantly, our in vivo lodging experiments suggest that this defect is related to impaired homing of transplanted cells. Furthermore, our shortterm lodging xenotransplants experiments in NOD/SCID mice showed that this novel role for the C3aR-C3a axis also seems to be relevant for homing of human CD34 þ cells. Thus, the C3a-C3aR axis plays an underappreciated role in homing of both human and murine HSPCs.
On the basis of these data, we postulate that activation of C cascade and release of C3a in BM after conditioning for transplantation not only primes responsiveness of HSPCs to SDF-1 gradient by a C3aR-independent lipid raft formationdependent mechanism, 18, 22, 23, 29 but also in addition, C3a directly engages C3aR on the surface of HSPCs and thus enhances homing of these cells to BM.
To better address the role of the C3aR-C3a axis in the early steps of homing and engraftment, we report here that murine HSPCs stimulated by C3a, but not desArg C3a, secrete more MMP-9 and adhere better to BM stroma. Thus, C3a-C3aR plays an important role in increasing secretion of MMP-9, which facilitates transmigration of HSPCs through the endothelial barrier, as well as by increasing the interaction of HSPCs with cells in the hematopoietic microenvironment. Furthermore, because desArg C3a was not able to compensate for the C3aR deficiency, we excluded that another C3aR, the C5L2 receptor, is not involved in these phenomena.
In our earlier work, we have also shown that another C3 cleavage fragment, iC3b, which is deposited during activation of C on the surface of damaged stroma cells in BM, increases tethering of HSPCs through the CR3 (CD11b/CD18) receptor. Figure 4 Complement 3a (C3a)-complement 3a receptor (C3aR) axis enhances expression of matrix metalloprotease-9 (MMP-9) by hematopoietic stem/progenitor cell. Sca-1 þ bone marrow cells from C3aR À/À or WT mice were non-stimulated or stimulated overnight by C3a (1 mg/ml) or desArg C3a (1 mg/ml), and mRNA was isolated for reverse transcriptase-PCR analysis of MMP-9 and MMP-2 expression (a). Supernatants were collected for MMP-9 analysis by zymography (b). The data shown represent the combined results from three independent experiments. *Po0.0001 for real-time quantitative-PCR. One representative zymography study is shown. Figure 5 Blocking of complement 3a receptor (C3aR) on human umbilical cord blood (UCB) CD34 þ cells impairs homing in non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice model. Human UCB CD34 þ cells were exposed or not exposed to C3aR antagonist SB 290157 and transplanted into lethally irradiated NOD/SCID mice. At 24 h later, bone marrow from the femora of transplanted mice was isolated, and the contents of human CFU-GM and femurs were evaluated in secondary in vitro cultures. The data shown represent the combined results from three independent experiments carried out with six mice per group each. *Po0.001. No colonies grew from lethally irradiated and control animals not transplanted with UCB cells (n ¼ 5).
This dual role of C3 cleavage fragments, that is, liquid-phase C3a and solid-phase iC3B, may explain why the engraftment defect in C3 À/À mice was somehow slightly more pronounced than that observed after transplantation of WT cells into C3aR À/À mice. It is obvious that C3aR À/À mice still express and activate C3 and thus iC3b is normally deposited on BM stroma cells, providing a proper tethering for transplanted HSPCs through CR3 (CD11b/CD18) receptor. 18 Our data also explain our earlier priming studies in vivo 22, 23, 29 showing that stimulation of HSPCs before transplantation with C3a, but not desArg C3a, accelerated engraftment of HSPCs into lethally irradiated WT mice. As desArg C3a does not activate C3aR, the short exposure of HSPCs before transplantation to C3a accelerates engraftment by activating the homing function of C3aR. To support this, and as we have shown in this work, C3a, but not desArg C3a, increased MMP-9 secretion and enhanced adhesion of HSPCs to BM stroma cells. By using C3aR À/À mice in this study, we clearly show that this effect is related to C3aR and another C3a binding receptor, C5L2, which also binds desArg C3a, cannot compensate for the C3aR deficiency. However, further research is required to identify whether other proteases are released from HSPCs in addition to MMP-9, and to identify which adhesion molecules are directly affected by the C3a-C3aR axis.
In conclusion, we show for the first time that the C3a-C3aR axis plays an underappreciated role in homing of HSPCs to BM. By using C3aR À/À mice, we excluded the involvement of the C5L2 receptor. Our data show that defective homing and engraftment of C3aR À/À HSPCs could be explained by the C3a-C3aR axis modulating secretion of MMP-9 by HSPCs, as well as their adhesion. Thus, C3a plays a dual role in homing and engraftment ( Figure 6 ). As reported earlier, the first is by an enhanced responsiveness of HSPCs to SDF-1 gradient through a C3aR independent mechanism. 18, 22, 28, 29 Secondly, and as shown here by engaging C3aR, it modulates several functions pertinent to transendothelial migration and homing (for example, secretion of proteases and adhesion). Figure 6 Stromal-derived factor-1 (SDF-1) and C3 cleavage fragments create 'super-gradient' for hematopoietic stem/progenitor cell (HSPC). Conditioning for transplantation by radio-chemotherapy upregulates in bone marrow (i) expression of SDF-1 12 and (ii) activates complement cascade. 18, 22, 23, 28, 29 Although SDF-1 directly chemoattracts HSPCs by interacting with CXCR4 receptor, our work showed that the homing function of the SDF-1-CXCR4 axis is modulated by C3 cleavage fragments (C3a and des ArgC3a)Fboth in complement 3a receptor (C3aR)-dependent and C3aR-independent manner. In a first mechanism, C3a (but not desArg C3a) activates C3aR and increases adhesiveness of HSPCs, as well as secretion of matrix metalloprotease-9 (MMP-9) by these cells. In a second one (C3aR-independent), both C3a and desArg C3a enhance/prime responsiveness of HSPCs to SDF-1 gradient by increasing incorporation of CXCR4 into membrane lipid rafts. CXCR4 incorporated in lipid rafts is better connected with signal transduction proteins that explains why CXCR4 þ HSPCs respond more robust to SDF-1. However, the identification of receptor/receptors involved in this C3a and desArgC3s-mediated 'priming' effect requires further studies.
